Product Information

METOCLOPRAMIDE 5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0352 per EA under NDC 00093220401. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Jun 15, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METOCLOPRAMIDE 5 MG TABLET

Metoclopramide
$0.0352per EA

Strength

5 mg/1

NDC

00093220401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA072801

FDA Approved

6/15/1993

TE Code

AB

On Market Since

7/1/1993

Pharmacological Classes

Dopamine D2 Antagonists
Dopamine-2 Receptor Antagonist

Price Statistics

The NADAC for METOCLOPRAMIDE 5 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 23.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0352 per EA
All-time high$0.0494 (May 13, 2015)
All-time low$0.0352 (Oct 21, 2026)
52-week high$0.0433
52-week low$0.0352
Median price$0.0429
Average price$0.0423
Largest weekly change-18.5% (Apr 17, 2024)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-1.7%

3M

-2.9%

6M

-5.1%

1Y

-17.6%

3Y

-20.9%

5Y

-25.6%

All

-23.7%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METOCLOPRAMIDE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0352 per EA (NDC 00093220401), effective Nov 11, 2026.

How has the price of METOCLOPRAMIDE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for METOCLOPRAMIDE 5 MG TABLET has declined 23.7%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 5 MG TABLET?

Since Nov 28, 2013, the NADAC for METOCLOPRAMIDE 5 MG TABLET has ranged from a low of $0.0352 (Oct 21, 2026) to a high of $0.0494 (May 13, 2015), with a median of $0.0429 per EA.

Are there cheaper alternatives to METOCLOPRAMIDE 5 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOCLOPRAMIDE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METOCLOPRAMIDE 5 MG TABLET?

METOCLOPRAMIDE 5 MG TABLET (NDC 00093220401) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.